something in the quarterly?, page-2

Really can't understand the mentality or mind set of these lemmings selling at 2c or less.

The last announcement re: the US Manufacturing was a huge positive and gives an insight that the OEM currently supplies to some of the worlds best known medical device suppliers.

Doesn't take too much thinking to assume that both ALT and the OEM will have direct access to some of the majors from this arrangement and will likely be approaching some already to showcase and market the product and conduct trials.

Remember we could be talking the likes of Johnson & Johnson, Baxter, GE Healthcare, Cardinal Health etc.

This is entirely seperate from their arrangement with MLA in Australia. ALT are dealing on their own terms in US and EUR.

Logical path forwards is:-

- product validation
- marketing to majors
- securing clinical trials
- purchase order or licensing

We have not had any negative news and are progressing well since the supply issues have been resolved.

This is also in addition to the Australian front where we have:-

- QLD hospital successful trial (awaiting news of orders and whether it involves QLD Health)
- NSW hospital trial results
- The fact MLA are current selling the burette with autoflush feature

The only reason for the SP to fall below 2c (where the directors contributed over $1M personally) is the need for another CR which is not the case or negative news which is also not the case.

Purely lemmings with loose stock and impatient trading styles. Alot are forgetting the day they announce a deal with said major, it will open at a multiple given the PE ratio this companies trade at.